Fast track publication of the STHLM3 MRI trial in The Lancet Oncology
Stockholm3 in combination with MRI enables implementation of population-based screening of prostate cancer The combination decreases unnecessary biopsies by 74 percent STOCKHOLM, August 13, 2021. A3P Biomedical AB today announced that the publication of the STHLM3 MRI trial including 12,750 men has been fast tracked and is now published…